FDA inspection

Faxon, David P., M.D.: FDA inspection ending Nov 11, 1999

FDA inspection 3407 · Official Action Indicated (OAI) · Los Angeles, CA

Key facts

Inspection ID	3407
Firm	Faxon, David P., M.D.
FEI number	3002852300
Address	1355 San Pablo St Ste 117
City	Los Angeles
State	CA
ZIP	90089-0111
Fiscal year	2000
Inspection end date	Nov 11, 1999
Classification	Official Action Indicated (OAI)
Project area	Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance\|Drug Quality Assurance
Product type	Drugs

At a glance

None Citations
1–9 Posted citations
No Warning letter followed
Yes Form FDA 483 issued
No Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections